Back to Results
First PageMeta Content
Amines / Alcohols / Selective serotonin reuptake inhibitors / Organochlorides / Serotonin-norepinephrine reuptake inhibitors / Antidepressant / Placebo / Major depressive disorder / Serotonin–norepinephrine reuptake inhibitor / Chemistry / Organic chemistry / Medicine


Microsoft Word - final-labeling-text[removed]doc
Add to Reading List

Open Document

File Size: 345,08 KB

Share Result on Facebook

Company

Human Experience / Case / Forest Laboratories Inc. / /

Event

FDA Phase / /

Facility

Laboratory Tests VIIBRYD / /

IndustryTerm

healthcare / food / treatment of major depressive disorder / /

MedicalCondition

hallucination / incoordination / insomnia / epistaxis / panic attacks / major depressive disorder / myoclonus / hyperreflexia / petechiae / obsessive compulsive disorder / flushing / headache / restless legs syndrome / Seizures / Gastroenteritis / bipolar depression / psychomotor restlessness / shock / Carcinogenesis / Erectile dysfunction / hallucinations / coma / nausea / seizure disorder / mania / hypersomnia / psychomotor agitation / Sexual dysfunction / lethargy / tremor / seizure / syncope / vomiting / Serotonin Syndrome / Hyponatremia / certain other psychiatric disorders / Angle closure glaucoma / psychiatric disorders / fatigue / Placebo Diarrhea / Treat Psychiatric Disorders / affective disorder / SIADH / tachycardia / diarrhea / delirium / Restlessness / Closure Glaucoma / dizziness / depression / paresthesia / tinnitus / syndrome / disorders / bipolar disorder / akathisia / /

MedicalTreatment

antidepressant therapy / drug therapy / /

Organization

US Federal Reserve / DOSAGE AND ADMINISTRATION / FDA / /

Person

Depressive Disorder / /

/

Position

Major / General / /

Product

linezolid / carbamazepine / DOSAGE FORMS AND STRENGTHS VIIBRYD Tablets / ketoconazole / fentanyl / erythromycin / VIIBRYD / /

Technology

Pharmacokinetics / Pharmacodynamics / /

URL

www.fda.gov/medwatch / /

SocialTag